Physician profile
Tara Mae Allen
NPI 1497966105
$99,825.40
in general payments reported to CMS, 2019-2025
40 companies · $20K in 2025
The $20K reported for 2025 was more than what 94% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $5,830 · 2021: $23K · 2022: $8,263 · 2023: $15K · 2024: $15K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Consulting Fee: $13K · Food and Beverage: $5,617 · Travel and Lodging: $3,647 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,433.88 |
| Consulting Fee | $12,820.30 |
| Food and Beverage | $5,617.15 |
| Travel and Lodging | $3,647.24 |
| Education | $125.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $61,506.31 | 2019-2025 | Solyx Sis System, General - Female Sui, Axonics |
| Axonics, INC. | $21,769.09 | 2020-2024 | Axonics, Bulkamid |
| Coloplast Corp | $11,115.28 | 2019-2025 | Speedicath |
| Astellas Pharma US INC | $886.01 | 2019-2024 | Veozah, Myrbetriq |
| C. R. Bard, INC. & Subsidiaries | $559.76 | 2023-2025 | Bard Urinary Drainage Bag, Purewick Female External Catheter |
| Urogen Pharma, INC. | $515.18 | 2020-2024 | Jelmyto |
| Sumitomo Pharma America, INC. | $483.64 | 2023-2025 | Gemtesa |
| Medtronic, INC. | $269.63 | 2021-2025 | Altaviva, Interstim |
| Allergan, INC. | $252.52 | 2019-2022 | |
| Abbvie INC. | $243.76 | 2022-2025 | Botox |
| Rochester Medical Corporation | $232.92 | 2021-2022 | |
| Angiodynamics, INC. | $212.99 | 2021-2022 | |
| Urovant Sciences INC | $174.35 | 2021-2022 | |
| Medtronic USA, INC. | $146.16 | 2019-2020 | |
| Contura, INC. | $145.56 | 2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $138.53 | 2022-2025 | Femring, Intrarosa |
| Hologic Sales and Service, LLC | $137.46 | 2024 | Coolseal Generator |
| Laborie Medical Technologies Corp. | $125.62 | 2021-2025 | Urgent Pc Neuromodulation System |
| 180 Medical, INC. | $94.27 | 2019-2024 | |
| Caldera Medical, INC | $86.14 | 2021 | |
| Ferring Pharmaceuticals INC. | $84.38 | 2019 | |
| Duchesnay USA Incorporated | $61.82 | 2019 | |
| Therapeuticsmd, INC. | $55.75 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $54.19 | 2024-2025 | |
| Dentsply Ih Ab | $46.42 | 2024-2025 | Lofric |
| Convatec INC. | $43.35 | 2023-2024 | |
| Mission Pharmacal Company | $41.31 | 2023-2024 | Uribel Tabs, Uribel |
| Palette Life Sciences, INC. | $40.26 | 2022 | |
| Valencia Technologies Corporation | $39.45 | 2025 | Ecoin Device Kit |
| Hollister Incorporated | $38.95 | 2023 | Infyna Chic |
| Abc Home Medical Supply, INC. | $38.75 | 2024-2025 | |
| Pfizer INC. | $38.00 | 2019 | |
| Zyla Life Sciences, INC. | $24.79 | 2019 | |
| Antares Pharma, INC. | $21.15 | 2021 | |
| Provepharm INC. | $19.56 | 2025 | Bludigo |
| Photocure INC | $17.67 | 2024 | Cysview |
| Solventum Corporation | $16.67 | 2024 | Promogran Prisma, Prevena Restor Arthroform, V.A.C.Instill |
| Sagent Pharmaceuticals | $16.67 | 2020 | |
| Travere Therapeutics, INC. | $15.95 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.